NCT01096589

Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Preliminary Study to Assess the Effectiveness of 3M Oedema Reduction System in the Treatment of Lymphoedema Treatment Compared to Comprilan Short-stretch Bandage Compression Therapy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: Solventum US LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging. Secondary objectives: * Assessment of safety * Quality of life * Health economic parameters * Slippage * Subbandage pressure

Conditions

• Lymphedema

Interventions

Type	Name	Description
DEVICE	3M Coban 2 (Compression System)	Nonwoven cohesive backing and foam.
DEVICE	3M Coban 2 (Compression System)	Nonwoven cohesive backing and foam.
DEVICE	3M Coban 2 (Compression System)	Nonwoven cohesive backing and foam.
DEVICE	Comprilan	Commercial short-stretch bandage (Comprilan; BSN Medical Ltd, Hull, U.K).

Timeline

• Start date: 2010-03-01
• Primary completion: 2010-10-01
• Completion: 2010-10-01
• First posted: 2010-03-31
• Last updated: 2024-10-02
• Results posted: 2012-11-27

Locations

11 sites across 2 countries: United States, United Kingdom